José Illnait Selected Research

policosanol

6/2008	Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
5/2006	Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study.
7/2004	Effects of policosanol and ticlopidine in patients with intermittent claudication: a double-blinded pilot comparative study.
9/2003	Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study.
1/2003	Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus.
1/2003	Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
1/2003	Effects of policosanol and lovastatin in patients with intermittent claudication: a double-blind comparative pilot study.
1/2002	Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Illnait Research Topics

Disease

4	Osteoarthritis 01/2017 - 01/2005
3	Pain (Aches) 01/2017 - 01/2005
3	Intermittent Claudication 06/2008 - 01/2003
3	Hypertension (High Blood Pressure) 01/2005 - 01/2002
3	Headache (Headaches) 01/2005 - 09/2003
2	Myalgia 01/2003 - 01/2003
2	Myocardial Infarction 01/2003 - 01/2002
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019
1	Arthralgia (Joint Pain) 01/2017
1	Non-alcoholic Fatty Liver Disease 07/2013
1	Insulin Resistance 07/2013
1	Weight Loss (Weight Reduction) 07/2013
1	Hyperplasia 05/2009
1	Hypercholesterolemia 05/2006
1	Duodenal Ulcer (Curling's Ulcer) 01/2005
1	Rheumatoid Arthritis 01/2005
1	Stomach Ulcer (Gastric Ulcer) 01/2005
1	Ulcer 01/2005
1	Unstable Angina 07/2004
1	Diarrhea 07/2004
1	Heartburn (Pyrosis) 09/2003
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2003
1	Gastritis 01/2003
1	Abdominal Pain (Pain, Abdominal) 01/2003
1	Pruritus (Itching) 01/2003
1	Muscle Cramp (Cramp) 01/2003
1	Type 2 Diabetes Mellitus (MODY) 01/2003
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2002
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2002
1	Coronary Disease (Coronary Heart Disease) 01/2002

Drug/Important Bio-Agent (IBA)

8	policosanolIBA 06/2008 - 01/2002
5	beeswaxIBA 01/2017 - 01/2005
5	D 002IBA 01/2017 - 01/2005
4	LipidsIBA 01/2019 - 01/2002
4	AlcoholsIBA 01/2017 - 07/2013
2	oxidized low density lipoproteinIBA 01/2003 - 01/2002
2	Atorvastatin (Lipitor)FDA Link 01/2003 - 01/2003
1	Terazosin (Hytrin)FDA LinkGeneric 01/2019
1	Glucosamine (Dona)IBA 01/2017
1	ChondroitinIBA 01/2017
1	AcidsIBA 01/2016
1	Testosterone (Sustanon)FDA Link 05/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2008
1	Analgesics (Analgesic Drugs)IBA 01/2005
1	Piroxicam (Feldene)FDA LinkGeneric 01/2005
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2005
1	Ethanol (Ethyl Alcohol)IBA 01/2005
1	Proton Pumps (Proton Pump)IBA 01/2005
1	Ticlopidine (Ticlid)FDA LinkGeneric 07/2004
1	Glucose (Dextrose)FDA LinkGeneric 01/2003
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2003
1	CholesterolIBA 01/2003

Therapy/Procedure

2	Therapeutics 01/2016 - 06/2008
1	Complementary Therapies (Alternative Medicine) 07/2013
1	Diet Therapy (Therapy, Diet) 07/2013